Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by made2laston Sep 22, 2017 11:18am

100 Views

Post# 26730796

RE:RE:RE:RE:Nasopharyngeal carcinoma: Keytruda overall efficacy = 22%

Hi bencro;

You can’t blame macman1519 for wanting a JV with Merck, you can’t ask for a stronger partner. However, Keytruda puts Merck in a bit of a dilemma. If I were them and had I had spent so much time and money on Keytruda, I would certainly need to follow through and continue, but on the other hand I would feel compelled to JV with a possible disruptors in order to hedge my investment if the disruptor has a strong possibility of harming my position. Is it not prudent for a well financed company to have a stake in other technologies. Also, the old axiom, “Keep your friends close, but keep your enemies even closer”. What do they do?

The best of luck to all longs;

made2last

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario